3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
3
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
7241
Neoplasms
4538
Prostatic Neoplasms
3489
Colorectal Neoplasms
2939
Carcinoma, Non-Small-Cell Lung
2829
Lung Neoplasms
2546
Leukemia, Myeloid, Acute
1982
Pancreatic Neoplasms
1873
Multiple Myeloma
1810
Carcinoma, Hepatocellular
1732
Neoplasm Metastasis
1585
Stomach Neoplasms
1501
Lymphoma
1456
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1435
Head and Neck Neoplasms
1434
Brain Neoplasms
1370
Melanoma
1346
Ovarian Neoplasms
1342
Leukemia
1303
Rectal Neoplasms
1270
Recurrence
1254
Colonic Neoplasms
1204
Glioblastoma
1137
Uterine Cervical Neoplasms
1096
Lymphoma, Non-Hodgkin
1065
Leukemia, Lymphocytic, Chronic, B-Cell
989
Esophageal Neoplasms
965
Lymphoma, Follicular
936
Lymphoma, Large B-Cell, Diffuse
932
Squamous Cell Carcinoma of Head and Neck
921
Interventions
salicylhydroxamic acid
1
Triamcinolone Acetonide
1
Ranibizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Macular Degeneration
×
Clear all
NCT02626377
2023-10-23
ICE
Centre Hospitalier Universitaire de Besancon
Phase NA
Terminated
186 enrolled
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled